{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:49:48Z","timestamp":1774442988777,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.es","semdiagpath.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1053\/j.semdp.2015.02.014","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T17:51:56Z","timestamp":1423072316000},"page":"334-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictive value of immunohistochemistry in pre-malignant lesions of the gastrointestinal tract"],"prefix":"10.1053","volume":"32","author":[{"given":"Changqing","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reetesh K.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2015.02.014_bib1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","article-title":"The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u02bcs oesophagus: a meta-analysis","volume":"61","author":"Desai","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.semdp.2015.02.014_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.gie.2007.07.019","article-title":"Incidence of esophageal adenocarcinoma in patients with Barrett\u02bcs esophagus and high-grade dysplasia: a meta-analysis","volume":"67","author":"Rastogi","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.semdp.2015.02.014_bib3","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2036.2001.01046.x","article-title":"A conceptual approach to understanding the molecular mechanisms of cancer development in Barrett\u02bcs oesophagus","volume":"15","author":"Souza","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.semdp.2015.02.014_bib4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0016-5085(93)91058-P","article-title":"p53 protein accumulation in Barrett\u02bcs metaplasia, dysplasia, and carcinoma: a follow-up study","volume":"105","author":"Younes","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semdp.2015.02.014_bib5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/gut.2005.083295","article-title":"TP53 and progression from Barrett\u02bcs metaplasia to oesophageal adenocarcinoma in a UK population cohort","volume":"55","author":"Murray","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.semdp.2015.02.014_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.gtc.2007.08.004","article-title":"Neoplastic precursor lesions in Barrett\u02bcs esophagus","volume":"36","author":"Hornick","year":"2007","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.semdp.2015.02.014_bib7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.5858\/arpa.2011-0019-RA","article-title":"A clinical and histopathologic focus on Barrett esophagus and Barrett-related dysplasia","volume":"135","author":"Voltaggio","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2015.02.014_bib8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.pas.0000213268.30468.b4","article-title":"AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett\u02bcs esophagus, ulcerative colitis, and Crohn\u02bcs disease","volume":"30","author":"Dorer","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib9","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.humpath.2006.06.009","article-title":"Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett\u02bcs epithelium","volume":"37","author":"Lisovsky","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/modpathol.2008.73","article-title":"Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett\u02bcs esophagus","volume":"21","author":"Scheil-Bertram","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/his.12216","article-title":"Value of alpha-methylacyl-CoA racemase immunochemistry for predicting neoplasticprogression in Barrett\u02bcs oesophagus","volume":"63","author":"Kastelein","year":"2013","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2015.02.014_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/PAI.0b013e318168598b","article-title":"p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus","volume":"16","author":"Lauwers","year":"2008","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2015.02.014_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1309\/AJCPO31THGVEUIDH","article-title":"Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus","volume":"130","author":"van Dekken","year":"2008","journal-title":"American journal of clinical pathology"},{"key":"10.1053\/j.semdp.2015.02.014_bib14","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1136\/gutjnl-2012-303594","article-title":"Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett\u02bcs oesophagus","volume":"62","author":"Kastelein","year":"2013","journal-title":"Gut"},{"key":"10.1053\/j.semdp.2015.02.014_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy vs. chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2015.02.014_bib16","first-page":"1063","article-title":"Amplification of Her-2\/neu oncogene in GERD\u2013Barrett\u02bcs metaplasia\u2013dysplasia\u2013adenocarcinoma sequence","volume":"60","author":"Mokrowiecka","year":"2013","journal-title":"Hepato-gastroenterology"},{"key":"10.1053\/j.semdp.2015.02.014_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2559.2012.04272.x","article-title":"Early HER2 dysregulation in gastric and oesophageal carcinogenesis","volume":"61","author":"Fassan","year":"2012","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2015.02.014_bib18","first-page":"25","article-title":"HER2 status in Barrett\u02bcs esophagus & esophageal cancer: a meta analysis","volume":"5","author":"Gowryshankar","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1053\/j.semdp.2015.02.014_bib19","series-title":"WHO Classification of Tumours of the Digestive System","first-page":"48","article-title":"Gastric carcinoma","author":"Lauwers","year":"2010"},{"key":"10.1053\/j.semdp.2015.02.014_bib20","series-title":"WHO Classification of Tumours of the Digestive System","first-page":"10","article-title":"Premalignant lesions of the digestive system","author":"Odze","year":"2010"},{"key":"10.1053\/j.semdp.2015.02.014_bib21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00000478-200210000-00004","article-title":"Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology","volume":"26","author":"Abraham","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/PAS.0b013e31815b890e","article-title":"Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia","volume":"32","author":"Park do","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/PAS.0b013e31817d7ff4","article-title":"Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/PAS.0b013e3181f623af","article-title":"Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting","volume":"34","author":"Park","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000000146","article-title":"Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms","volume":"38","author":"Wood","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib26","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/PAS.0000000000000185","article-title":"Pyloric gland adenoma in Lynch syndrome","volume":"38","author":"Lee","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00428-010-0968-7","article-title":"Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53","volume":"457","author":"Vieth","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2015.02.014_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jso.22090","article-title":"Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer","volume":"105","author":"Kim","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semdp.2015.02.014_bib29","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","article-title":"Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater","volume":"31","author":"Chang","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2015.02.014_bib30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","article-title":"The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater","volume":"38","author":"Ang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib31","series-title":"WHO Classification of Tumours of the Digestive System","first-page":"83","article-title":"Adenomas and other premaliganant neoplastic lesion","author":"Klimstra","year":"2010"},{"key":"10.1053\/j.semdp.2015.02.014_bib32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/PAS.0b013e3181983ef7","article-title":"Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions","volume":"33","author":"Ruemmele","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.4200","article-title":"Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma\/polyp","volume":"230","author":"Gonzalo","year":"2013","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/PAS.0000000000000148","article-title":"Immunohistochemistry for annexin A10 can distinguish sporadic from Lynch syndrome-associated microsatellite-unstable colorectal carcinoma","volume":"38","author":"Pai","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/modpathol.2012.98","article-title":"Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status","volume":"25","author":"Patil","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.humpath.2013.10.026","article-title":"Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization","volume":"45","author":"Kuan","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/his.12154","article-title":"Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma","volume":"63","author":"Adackapara","year":"2013","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2015.02.014_bib38","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/cncr.28133","article-title":"Mutation-specific antibody detects mutant BRAFV600E protein expression in human colon carcinomas","volume":"119","author":"Sinicrope","year":"2013","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2015.02.014_bib39","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0000000000000229","article-title":"Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach","volume":"38","author":"Lasota","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/modpathol.2013.126","article-title":"Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E","volume":"27","author":"Mesteri","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2008.55","article-title":"Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps","volume":"21","author":"Owens","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/modpathol.2009.155","article-title":"Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps","volume":"23","author":"Bartley","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib43","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/modpathol.2011.55","article-title":"A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas","volume":"24","author":"Mojtahed","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/modpathol.2011.209","article-title":"Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry","volume":"25","author":"Walsh","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2353\/jmoldx.2009.080142","article-title":"Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas","volume":"11","author":"Pino","year":"2009","journal-title":"J Mol Diagn"},{"key":"10.1053\/j.semdp.2015.02.014_bib46","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/1940-6207.CAPR-11-0519","article-title":"Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps","volume":"5","author":"Yurgelun","year":"2012","journal-title":"Cancer Prev Res"},{"key":"10.1053\/j.semdp.2015.02.014_bib47","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s10620-014-3245-9","article-title":"Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic","volume":"59","author":"Kushnir","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.semdp.2015.02.014_bib48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1572-0241.2005.40862.x","article-title":"Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines","volume":"100","author":"Velayos","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1053\/j.semdp.2015.02.014_bib49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5858\/arpa.2012-0086-RA","article-title":"Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology","volume":"137","author":"Matkowskyj","year":"2013","journal-title":"Arch Pathol Lab Med."},{"key":"10.1053\/j.semdp.2015.02.014_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2013.133","article-title":"Diagnostic utility of TP53 and cytokeratin 7 immunohistochemistry in idiopathic inflammatory bowel disease-associated neoplasia","volume":"27","author":"Xie","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13402-010-0006-4","article-title":"Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study","volume":"34","author":"Gerrits","year":"2011","journal-title":"Cell Oncol"},{"key":"10.1053\/j.semdp.2015.02.014_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.humpath.2008.06.027","article-title":"Combined alpha-methylacyl coenzyme A racemase\/p53 analysis to identify dysplasia in inflammatory bowel disease","volume":"40","author":"Marx","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib53","first-page":"3333","article-title":"Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease","volume":"60","author":"Hussain","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2015.02.014_bib54","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ibd.21722","article-title":"Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis","volume":"18","author":"van Schaik","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.semdp.2015.02.014_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2559.2007.02923.x","article-title":"Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett\u02bcs and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia","volume":"52","author":"Strater","year":"2008","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2015.02.014_bib56","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2015.02.014_bib57","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/PAS.0b013e31828706c0","article-title":"p16 is superior to ProEx C in identifying high-grade squamous intraepithelial lesions (HSIL) of the anal canal","volume":"37","author":"Bala","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2015.02.014_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/PAI.0b013e3181454a95","article-title":"Anal intraepithelial neoplasia: correlation of grade with p16INK4a immunohistochemistry and HPV in situ hybridization","volume":"16","author":"Bernard","year":"2008","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2015.02.014_bib59","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/01.pas.0000208283.14044.a9","article-title":"P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia","volume":"30","author":"Walts","year":"2006","journal-title":"Am J Surg Pathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257015000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257015000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T01:01:05Z","timestamp":1717722065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257015000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0740257015000155"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2015.02.014","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of immunohistochemistry in pre-malignant lesions of the gastrointestinal tract","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2015.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}